Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Total 13F shares
-
4,497,093
-
Share change
-
+3,541,204
-
Total reported value
-
$345,558,108
-
Put/Call ratio
-
24%
-
Price per share
-
$76.84
-
Number of holders
-
88
-
Value change
-
+$271,922,798
-
Number of buys
-
57
-
Number of sells
-
16
Institutional Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q2 2022
As of 30 Jun 2022,
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) was held by
88 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,497,093 shares.
The largest 10 holders included
Phoenix Holdings Ltd., UBS Group AG, GOLDMAN SACHS GROUP INC, MORGAN STANLEY, Noked Israel Ltd, Noked Capital LTD, BANK OF AMERICA CORP /DE/, ALTFEST L J & CO INC, ROYAL BANK OF CANADA, and JANE STREET GROUP, LLC.
This page lists
90
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.